Latest filing published 06 Sept 2017 for Pediapharm Inc., €20k.
Sylvain Chretien discloses dealings in Pediapharm Inc. to SEDI. Over a trading history stretching from 27 July 2016 to 1 September 2017, the count stands at 6 filings.
Purchases make up the whole of the open-market record (3 purchases, €3,470). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
Half of the purchases are above €1,093 and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 6 September 2017, reports a transaction of €20k in Pediapharm Inc. The most recent open-market purchase was published on 28 July 2016, 3,740 days ago. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations